Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs NuDay Rx

Belle Health
Graded #48

Higher grade

vs+10.099999999999994
NuDay Rx
Graded #175

Lower grade

The verdict

Belle Health takes it — 77/100 to 66.9/100.

Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +44
92
48
Dose & formulationNuDay Rx +16
72
88
Clinical oversightNuDay Rx +3
71
74
Labs & monitoringBelle Health +10
72
62
FulfillmentBelle Health +12
85
73
Contract termsEven
55
55
Belle Health · left barNuDay Rx · right bar

The numbers

MetricBelle HealthNuDay Rx
WeighScore77/10066.9/100
GradeC+C
Scorecard rank#48#175
Semaglutide$119/mo$249/mo (compounded)
Tirzepatide$199/mo (all doses, 3-month plan, compounded)$329/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Belle Health

Graded #48 · C+

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
NuDay Rx

Graded #175 · C

Strengths

  • Wide selection — compounded semaglutide ($249) and tirzepatide ($329), oral tablet options, plus brand GLP-1 (cash pay)
  • Includes video coaching and lifestyle support with a licensed-doctor consult
  • Full legal suite published (Terms, Privacy, Privacy Practices, Medical Consent)
  • Prescription delivered to your door after an online intake and consult

Where it loses points

  • Compounded semaglutide ($249) is pricier than some budget competitors
  • Compounding pharmacy partner not named
  • Not LegitScript-certified (no certification displayed)
  • Runs on a shared white-label telehealth platform (CareValidate/careGLP)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard